Integrated Wealth Counsel’s Pfizer PFE Stock Holding History

Integrated Wealth Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$537K	Hold	17,410	–	–	1.15%	16
2016 Q3	$559K	Buy	+17,410	New	+$582K	1.18%	14
2015 Q2	–	Sell	-1,896	Closed	-$63K	–	91
2015 Q1	$63K	Hold	1,896	–	–	0.08%	52
2014 Q4	$56K	Hold	1,896	–	–	0.07%	55
2014 Q3	$53K	Hold	1,896	–	–	0.05%	55
2014 Q2	$53K	Hold	1,896	–	–	0.04%	69
2014 Q1	$58K	Hold	1,896	–	–	0.05%	88
2013 Q4	$55K	Hold	1,896	–	–	0.04%	96
2013 Q3	$51.7K	Hold	1,896	–	–	0.04%	98
2013 Q2	$50K	Buy	+1,896	New	+$52.4K	0.04%	101

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Integrated Wealth Counsel's PFE Position: Q4 2016 in Review

Integrated Wealth Counsel held its Pfizer (PFE) position steady in Q4 2016 at 17,410 shares worth $537K. The position accounts for 1.15% of the portfolio, ranked #16.

Integrated Wealth Counsel first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. The position peaked at $559K in Q3 2016. 2,060 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

Integrated Wealth Counsel held 17,410 shares of Pfizer worth $537K as of Q4 2016.
Integrated Wealth Counsel left its Pfizer share count unchanged in Q4 2016.
Pfizer made up 1.15% of Integrated Wealth Counsel's portfolio in Q4 2016, its #16 holding.
Integrated Wealth Counsel first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
Integrated Wealth Counsel's Pfizer position peaked at $559K in Q3 2016.
2,060 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Integrated Wealth Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.